Rankings
▼
Calendar
ARVN FY 2025 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$907M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$263M
-0.3% YoY
Gross Profit
$257M
98.0% margin
Operating Income
-$115M
-43.8% margin
Net Income
-$81M
-30.8% margin
EPS (Diluted)
$-1.28
Cash Flow
Operating Cash Flow
-$274M
Free Cash Flow
-$276M
Stock-Based Comp.
$44M
Balance Sheet
Total Assets
$718M
Total Liabilities
$284M
Stockholders' Equity
$434M
Cash & Equivalents
$143M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$263M
$263M
-0.3%
Gross Profit
$257M
$263M
-2.3%
Operating Income
-$115M
-$250M
+54.1%
Net Income
-$81M
-$199M
+59.4%
← Q4 2024
All Quarters
Q1 2025 →